S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017

S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017

If signed into law, S. 1348 would mandate pharmaceutical companies to explain any price increase of over 100% of the value of any drug.

Senator Ron Wyden of Oregon introduced S. 1348 on June 13,2017. The bill has since been referred to the Senate Committee on Finance.

Learn more about S.1348 here

Print Friendly

Close